Resources | Cellgenetherapyreview.com

Detect mycoplasma at 10 GC/mL even when sample volume is limited
Limited sample volume can make mycoplasma testing especially difficult in cell therapy workflows, where material is often scarce and every milliliter matters. This application note presents a low-... read more
Evaluating cost drivers in scalable iPSC cell therapy manufacturing
As cell therapy development advances toward broader patient access, manufacturing strategy increasingly determines scalability, cost, and commercial feasibility. Autologous models remain constrained ... read more
Transient cell line for high-yield, scalable rAAV production
With high performance and enhanced quality, the ELEVECTA™ transient cell line paired with HyClone™ prime expression medium is designed to minimize development time and quickly advance promising ... read more
Close gaps in culture-based testing before they delay product release
Culture-based contamination detection can extend timelines and may not detect every relevant organism fast enough for today’s cell therapy workflows. This application note reviews data from a qPCR-... read more
Unlocking Primary Cell Transfection
ProteanFect™ TuffCell Transfection Kit is a novel, protein-based system designed to deliver nucleic acids efficiently and safely into difficult-to-transfect cell types. Using a coacervate-based ... read more

The operational realities of CAR-T cell therapies
CAR-T cell therapy has achieved what once seemed impossible — genetically reprogramming a patient's own immune cells to hunt down and destroy cancer. But as the science races forward, the realities of... read more

Connecting for quality: Powering cGMP for cell and gene therapies
In this infographic, review the most common cGMP hurdles faced in the CGT industry, and the automation and digital solutions that are helping the industry move forward. read more
The global compliance puzzle: CGT regulatory considerations
In this infographic, explore common global regulatory hurdles, and the digital solutions that can complete the global compliance puzzle. read more
[Infographic] Strategies for overcoming challenges in cell and gene therapy manufacturing
The production of cell and gene therapies comes with a set of challenges, including scalability, compliance, and accuracy. Manufacturing execution systems (MES) that incorporate digital process ... read more

Beyond CAR-T: Building manufacturing strategies for the next generation of regenerative cell therapies
As cell and gene therapy shifts toward in vivo approaches and regenerative modalities — iPSCs, MSCs, HSCs, and beyond — sponsors face new challenges beyond traditional CAR-T manufacturing: bioreactor ...
Automation & robotics: The path to scalable cell therapy manufacturing
As CAR-T therapies mature and look to scale out, a current barrier exists between the number of patients in need of these therapies and highly skilled operator availability. Automation in ...
[Interview] Engineering the future of neuromuscular gene therapy
Karen Langhauser is joined by Kasturi Sengupta, Ph.D., to discuss how AAV vector design, serotype selection, and delivery strategies are shaping the future of neuromuscular gene therapy.

HyClone™ Boost Expression Supplements
HyClone™ boost expression supplements, in combination with HyClone peak expression or prime expression media, improve AAV productivity in HEK293 systems, enabling higher yields and consistently delivering a two-fold or more improvement in transient ... read more
Fetal Bovine Serum, 500 mL, Australian Origin
Features Collected at government registered facilities in Australia. Exported from the country of origin accompanied with a Veterinarian Health Certificate and imported under a USDA-APHIS issued import permit. True pooled and triple 0.1 micron... read more
Gemini 3 µm NX-C18 250 mm x 4.6 mm
Gemini columns are rugged reversed phase HPLC columns that offer extended lifetime at extreme pH conditions and excellent stability for reproducible‚ high efficiency separations. TWIN-NX technology uses an improved patented organo-silica grafting ... read more